Acute myeloid leukemia discovery tackles drug-resistant gene mutations

Indiana University School of Medicine researchers and their collaborators have uncovered molecular insights expected to enhance treatment options for acute myeloid leukemia (AML), a rare and severe blood and bone marrow cancer. 

Read More